# MINPP1

## Overview
MINPP1, or multiple inositol-polyphosphate phosphatase 1, is a gene that encodes an enzyme belonging to the histidine phosphatase family. This enzyme is primarily localized in the endoplasmic reticulum (ER) lumen and plays a critical role in the metabolism of inositol polyphosphates, such as inositol hexakisphosphate (IP6) and inositol pentakisphosphate (IP5) (Chi1999Multiple; Ucuncu2020MINPP1). By dephosphorylating these substrates, the MINPP1 protein helps maintain cellular inositol-polyphosphate homeostasis, which is essential for regulating intracellular calcium and iron levels (Ucuncu2020MINPP1). The enzyme's activity is linked to various cellular processes, including cell growth regulation, apoptosis, and potentially bone and cartilage formation (Yu2023Multiple). Alterations in MINPP1 expression or function have been implicated in several clinical conditions, including hepatocellular carcinoma and neurodegenerative disorders such as pontocerebellar hypoplasia (Chen2021Hepatitis; Appelhof2020Pontocerebellar).

## Structure
The human MINPP1 protein is composed of 487 amino acids, with a predicted molecular mass of 55.1 kDa, or 52.4 kDa without the putative signal sequence (Chi1999Multiple). It is a member of the histidine phosphatase family and is characterized by a conserved active site sequence, Arg-His-Gly-X-Arg-X-Pro (RHGXRXP), which is crucial for its catalytic mechanism involving a temporary covalent phosphohistidine bond (Chi1999Multiple). The protein contains a C-terminal ER retention signal, a variant of the KDEL sequence, which is important for its localization within the cell (Chi1999Multiple).

MINPP1 is glycosylated, with two predicted N-glycosylation sites confirmed by PNGase enzyme treatment (Ucuncu2020MINPP1). The protein is primarily localized in the endoplasmic reticulum (ER) lumen, where it plays a role in the removal of phosphate groups from inositol polyphosphate substrates (Ucuncu2020MINPP1). The molecular weight of the immunoprecipitated MINPP1 protein is approximately 58 kDa, which is close to the predicted size based on its amino acid composition (Kilaparty2016Endoplasmic). The protein's structure and function are conserved across species, indicating its significant role in inositol polyphosphate metabolism (Chi1999Multiple).

## Function
MINPP1, or multiple inositol-polyphosphate phosphatase 1, is an enzyme primarily located in the endoplasmic reticulum (ER) lumen, where it plays a crucial role in the metabolism of inositol polyphosphates, particularly inositol hexakisphosphate (IP6) and inositol pentakisphosphate (IP5) (Ucuncu2020MINPP1; Yu2023Multiple). This enzyme dephosphorylates these inositol polyphosphates to lower phosphorylated forms, which is essential for maintaining cellular inositol-polyphosphate homeostasis and preventing the accumulation of IP6 (Ucuncu2020MINPP1). 

MINPP1's activity is vital for regulating intracellular calcium and iron levels, as IP6 can chelate these cations, affecting their availability and homeostasis (Ucuncu2020MINPP1). The enzyme's function is linked to various cellular processes, including cell growth regulation, apoptosis, and possibly bone and cartilage formation (Yu2023Multiple). In the absence of MINPP1, there is a significant depletion of free basal calcium levels, which impacts calcium signaling and homeostasis, particularly in neural progenitors (Ucuncu2020MINPP1). 

MINPP1 is also involved in the inositol phosphate cycle, contributing to the regulation of metabolic and secondary messenger functions within cells (Ucuncu2020MINPP1). Its role in maintaining proper inositol phosphate metabolism is crucial for healthy cellular function, particularly in neural progenitors and differentiating neurons (Ucuncu2020MINPP1).

## Clinical Significance
Mutations and alterations in the expression of the MINPP1 gene have significant clinical implications. In the context of hepatocellular carcinoma (HCC) associated with hepatitis B virus (HBV), MINPP1 is downregulated, which is linked to increased tumor proliferation and invasion. This downregulation is mediated by miRNA-30b-5p, which is upregulated in HBV-positive HCC and suppresses MINPP1 expression, promoting tumor growth through a glycolytic bypass pathway (Chen2021Hepatitis). High expression of MINPP1 is associated with favorable survival outcomes in HBV-positive HCC patients, suggesting its potential as a biomarker for this cancer type (Chen2021Hepatitis).

In neurodegenerative disorders, mutations in MINPP1 are linked to pontocerebellar hypoplasia (PCH), a severe early-onset condition. These mutations lead to an imbalance in inositol phosphates, resulting in increased levels of inositol hexakisphosphate (IP6) and disruptions in cation homeostasis, particularly affecting calcium and iron levels. This imbalance contributes to neurodegeneration and is associated with severe neurological symptoms such as intellectual disability and ataxia (Appelhof2020Pontocerebellar; Ucuncu2020MINPP1). The identification of MINPP1 mutations in PCH highlights its role in maintaining cellular homeostasis and its potential impact on brain development (Ucuncu2020MINPP1).

## Interactions
MINPP1 interacts with various proteins and nucleic acids, playing a significant role in cellular signaling pathways. In the context of HBV-positive hepatocellular carcinoma (HCC), MINPP1 is involved in a regulatory axis with the HBV protein HBp and the transcription factor FOXO3. This interaction leads to the upregulation of miRNA-30b-5p, which subsequently suppresses MINPP1 expression. This suppression is linked to the glycolytic bypass, a metabolic pathway that supports tumor growth (Chen2021Hepatitis).

MINPP1 is also involved in the dephosphorylation of inositol hexakisphosphate (InsP6) and other inositol phosphates, which is crucial for regulating cellular processes such as tumor cell proliferation. The enzyme's activity in dephosphorylating InsP6 is linked to its role in tumor cell growth, as it can convert InsP6 to other inositol phosphates within lysosomes, influencing cell proliferation (Windhorst2013Tumour).

Additionally, MINPP1's expression and activity are associated with cellular stress responses, particularly in endoplasmic reticulum (ER) stress-induced apoptosis. It is suggested that MINPP1 may interact with pathways involved in the unfolded protein response (UPR), potentially linking ER stress to mitochondrial apoptosis (Kilaparty2016Endoplasmic).


## References


[1. (Yu2023Multiple) Jia Yu, Barbara Leibiger, Shao-Nian Yang, Stephen B. Shears, Ingo B. Leibiger, Per-Olof Berggren, and Christopher J. Barker. Multiple inositol polyphosphate phosphatase compartmentalization separates inositol phosphate metabolism from inositol lipid signaling. Biomolecules, 13(6):885, May 2023. URL: http://dx.doi.org/10.3390/biom13060885, doi:10.3390/biom13060885. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biom13060885)

[2. (Chi1999Multiple) Hongbo Chi, George E. Tiller, Majed J. Dasouki, Paul R. Romano, Jun Wang, Regis J. O’Keefe, J.Edward Puzas, Randy N. Rosier, and Paul R. Reynolds. Multiple inositol polyphosphate phosphatase: evolution as a distinct group within the histidine phosphatase family and chromosomal localization of the human and mouse genes to chromosomes 10q23 and 19. Genomics, 56(3):324–336, March 1999. URL: http://dx.doi.org/10.1006/GENO.1998.5736, doi:10.1006/geno.1998.5736. This article has 70 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/GENO.1998.5736)

[3. (Appelhof2020Pontocerebellar) Bart Appelhof, Matias Wagner, Julia Hoefele, Anja Heinze, Timo Roser, Margarete Koch-Hogrebe, Stefan D. Roosendaal, Mohammadreza Dehghani, Mohammad Yahya Vahidi Mehrjardi, Erin Torti, Henry Houlden, Reza Maroofian, Farrah Rajabi, Heinrich Sticht, Frank Baas, Dagmar Wieczorek, and Rami Abou Jamra. Pontocerebellar hypoplasia due to bi-allelic variants in minpp1. European Journal of Human Genetics, 29(3):411–421, November 2020. URL: http://dx.doi.org/10.1038/s41431-020-00749-x, doi:10.1038/s41431-020-00749-x. This article has 14 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41431-020-00749-x)

[4. (Chen2021Hepatitis) Wenbiao Chen, Jingjing Jiang, Lan Gong, Zheyue Shu, Dairong Xiang, Xujun Zhang, Kefan Bi, and Hongyan Diao. Hepatitis b virus p protein initiates glycolytic bypass in hbv-related hepatocellular carcinoma via a foxo3/mirna-30b-5p/minpp1 axis. Journal of Experimental &amp; Clinical Cancer Research, January 2021. URL: http://dx.doi.org/10.1186/s13046-020-01803-8, doi:10.1186/s13046-020-01803-8. This article has 72 citations.](https://doi.org/10.1186/s13046-020-01803-8)

[5. (Windhorst2013Tumour) Sabine Windhorst, Hongying Lin, Christine Blechner, Werner Fanick, Laura Brandt, Maria A. Brehm, and Georg W. Mayr. Tumour cells can employ extracellular ins(1,2,3,4,5,6)p6 and multiple inositol-polyphosphate phosphatase 1 (minpp1) dephosphorylation to improve their proliferation. Biochemical Journal, 450(1):115–125, January 2013. URL: http://dx.doi.org/10.1042/bj20121524, doi:10.1042/bj20121524. This article has 47 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20121524)

[6. (Kilaparty2016Endoplasmic) Surya P. Kilaparty, Rakhee Agarwal, Pooja Singh, Krishnaswamy Kannan, and Nawab Ali. Endoplasmic reticulum stress-induced apoptosis accompanies enhanced expression of multiple inositol polyphosphate phosphatase 1 (minpp1): a possible role for minpp1 in cellular stress response. Cell Stress and Chaperones, 21(4):593–608, July 2016. URL: http://dx.doi.org/10.1007/s12192-016-0684-6, doi:10.1007/s12192-016-0684-6. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12192-016-0684-6)

[7. (Ucuncu2020MINPP1) Ekin Ucuncu, Karthyayani Rajamani, Miranda S. C. Wilson, Daniel Medina-Cano, Nami Altin, Pierre David, Giulia Barcia, Nathalie Lefort, Céline Banal, Marie-Thérèse Vasilache-Dangles, Gaële Pitelet, Elsa Lorino, Nathalie Rabasse, Eric Bieth, Maha S. Zaki, Meral Topcu, Fatma Mujgan Sonmez, Damir Musaev, Valentina Stanley, Christine Bole-Feysot, Patrick Nitschké, Arnold Munnich, Nadia Bahi-Buisson, Catherine Fossoud, Fabienne Giuliano, Laurence Colleaux, Lydie Burglen, Joseph G. Gleeson, Nathalie Boddaert, Adolfo Saiardi, and Vincent Cantagrel. Minpp1 prevents intracellular accumulation of the chelator inositol hexakisphosphate and is mutated in pontocerebellar hypoplasia. Nature Communications, November 2020. URL: http://dx.doi.org/10.1038/s41467-020-19919-y, doi:10.1038/s41467-020-19919-y. This article has 34 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-020-19919-y)